Astellas Pharma Inc. will invest $12.5 million in two innovation incubators operated by LabCentral, a U.S.-based lab facility for next-generation biotech start-ups. Astellas has previously committed more than $1 billion to drive innovation in Massachusetts to accelerate the discovery and development of potential breakthrough therapies in areas of significant unmet need. “Astellas has a long-standing commitment to the Boston-area life sciences ecosystem, where world-class talent are dedi...